Download PDF
Thromb Haemost 2009; 101(03): 413-414
DOI: 10.1160/TH08-12-0820
Editorial Focus
Schattauer GmbH

Software support for ‘doing the right thing right’

Joseph L. Dorsey
Harvard Vanguard Medical Associates, Internal/Hospital Medicine, Walpole, Massachusetts, USA
› Author Affiliations
Further Information

Publication History

Received: 16 December 2008

Accepted: 16 February 2008

Publication Date:
24 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Mant J, Hobbs FDR, Fletcher K. et al. Warfarin vs. Aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study (BAFTA): a Randomised controlled trial. Lancet 2007; 370: 493-503.
    CrossrefPubMedGoogle Scholar
  • 2 Ansell J, Caro JJ, Salas M. et al. Quality of clinical documentation and anticoagulation control in patients with chronic nonvalvular atrial fibrillation in routine medical care. Am J Med Qual 2007; 22: 327-333.
    CrossrefPubMedGoogle Scholar
  • 3 Centers for Medicare & Medicaid Services (CMS): Decision memo for prothrombin time (INR) monitor for home anticoagulation management (CAG-00087R). 03/19/08.
    PubMedGoogle Scholar
  • 4 Ansell J, Hirsh J, Hylek E. et al. Table 7 in Pharmacology and management of the vitamin K antagonists. Chest 2008; 133: 183S.
    CrossrefPubMedGoogle Scholar
  • 5 Garcia DA, Witt DM, Hylek E. et al. Delivery of optimized anticoagulant therapy: Consensus statement from The Anticoagulation Forum. Ann Pharmacother 2008; 42: 978-988.
    PubMedGoogle Scholar
  • 6 Oertel LB, Mungall D. Software applications in anticoagulation management. In: Managing oral anticoagulation therapy: clinical and operational guidelines. 2005. Wolters Kluwer Health, Inc.;
    Google Scholar
  • 7 Poller L, Keown M, Ibrahim S. et al. A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. Thromb Haemost 2009; 101: 487-494.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Campbell PM, Radensky PW, Denham CR. Economic analysis of systematic anticoagulation management vs. routine medical care for patients on oral warfarin therapy. Dis Manag Clin Outcomes 2000; 2: 1-8.
    PubMedGoogle Scholar
  • 9 Lafata JE, Martin SA, Kaatz S. et al. The cost-effectiveness of different management strategies for patients on chronic warfarin therapy. J Gen Intern Med 2000; 15: 31-37.
    CrossrefPubMedGoogle Scholar
  • 10 Lesko LJ. Response letter from FDA (to a letter to FDA from AC Forum BOD). Anticoagulation Forum 2007; 11: 1-5.
    PubMedGoogle Scholar
  • 11 Shurin SB, Nabel LG. Pharmacogenomics-ready for prime time?. New Engl J Med 2008; 358: 1061-1063.
    CrossrefPubMedGoogle Scholar